HUMA
Humacyte, Inc.
+0.01 (+2.49%)0.58USD1.0M成交股數162M市值–本益比(近四季)76.5股價營收比+34.9%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 406K-21% | 495K | 753K | 301K | 517K | 0 | 0 | 0 | 0 | – | – | – |
| 營業成本 | 1.2M | 2.0M | 260K | 213K | 147K | 0 | 0 | 0 | 0 | – | – | – |
| 毛利 | −825K-323% | −1.5M | 493K | 88K | 370K | 0 | 0 | 0 | 0 | – | – | – |
| 毛利率 | -203.2% | -311.7% | 65.5% | 29.2% | 71.6% | – | – | – | – | – | – | – |
| 研發費用 | 18.1M | 19.5M | 17.3M | 22.0M | 15.4M | 20.7M | 22.9M | 23.8M | 21.3M | 18.6M | 20.5M | 17.3M |
| 銷售管理費用 | 8.0M | 7.9M | 7.6M | 7.8M | 8.1M | 7.4M | 7.3M | 5.7M | 5.3M | 6.1M | 6.2M | 5.2M |
| 營業利益 | −27.0M+16% | −28.9M+3% | −24.4M-19% | −29.7M+1% | −23.2M-13% | −28.1M+14% | −30.2M+13% | −29.5M+31% | −26.6M | −24.6M | −26.7M | −22.5M |
| 營業利益率 | -6,649.3% | -5,845.5% | -3,239.0% | -9,876.1% | -4,484.3% | – | – | – | – | – | – | – |
| 稅後淨利 | −36.8M-194% | −17.6M-16% | −17.5M-55% | −37.7M-34% | 39.1M-223% | −20.9M-19% | −39.2M+73% | −56.7M+53% | −31.9M | −26.0M | −22.7M | −37.0M |
| 淨利率 | -9,064.5% | -3,559.4% | -2,325.4% | -12,511.0% | 7,570.4% | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.16-157% | -0.09-44% | -0.11-67% | -0.24-50% | 0.28-197% | -0.16-36% | -0.33+50% | -0.48+33% | -0.29 | -0.25 | -0.22 | -0.36 |
| 稀釋股數 | 234M | 198M | 158M | 155M | 132M | 118M | 119M | 119M | 108M | 103M | 103M | 103M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 79.9M | 48.5M | 19.5M | 38.0M | 62.8M | 44.9M | 20.6M | 93.6M | 116M | 100.0M | 115M | 130M |
| 應收帳款 | 330K | 434K | 1.1M | 394K | 488K | 0 | – | – | – | 0 | 0 | 0 |
| 存貨 | 7.0M | 9.9M | 18.4M | 11.1M | 8.0M | 0 | – | – | – | – | – | – |
| 總資產 | 138M | 111M | 91.5M | 139M | 163M | 138M | 115M | 138M | 161M | 149M | 168M | 183M |
| 有息負債 | 36.3M | 35.9M | – | – | – | 0 | – | – | – | – | – | – |
| 總負債 | 107M | 98.9M | 96.3M | 135M | 127M | 191M | 178M | 167M | 135M | 112M | 107M | 101M |
| 股東權益 | 31.3M | 11.6M | −4.8M | 4.1M | 36.0M | −52.7M | −63.7M | −28.3M | 26.2M | 37.0M | 61.1M | 81.9M |
| 負債比 | 77.4% | 89.5% | 105.2% | 97.1% | 77.8% | 138.2% | 155.5% | 120.5% | 83.8% | 75.2% | 63.6% | 55.2% |
| 淨現金(現金 − 有息負債) | 43.6M | 12.7M | – | – | – | 44.9M | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −25.1M | – | – | −28.6M+5% | – | – | – | −27.3M | – | – | −18.6M |
| 資本支出 | – | 175K | – | – | 228K | – | – | – | 391K | – | – | 1.2M |
| 自由現金流 | – | −25.3M | – | – | −28.8M+4% | – | – | – | −27.7M | – | – | −19.8M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -5,106.9% | – | – | -5,576.2% | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 2.0M
| 產品 | 1.4M | 68.2% | – |
|---|---|---|---|
| Product And Service Other | 649K | 31.8% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.0M | – | −40.8M | -2,003.6% | -0.26 | −106M |
| FY2024 | 0 | – | −149M | –% | -1.26 | −99.7M |
| FY2023 | – | – | −111M | –% | -1.07 | −75.6M |
| FY2022 | – | – | −12.0M | –% | -0.12 | −72.2M |
| FY2021 | – | – | −26.5M | –% | -0.66 | −81.4M |
| FY2020 | – | – | −66.5M | –% | -11.54 | −55.9M |